Antigen presentation, together with the induction of co-stimulatory signals mediated by the binding of CD28 on the T cell to CD80/CD86 on the APC, leads to the differentiation of naïve CD8+ T cells into tumor-specific CTLs. Here, CD8A is linked to neoplasm.